Microbiome Diversity
Bristol Myers reports progress in multiple myeloma trial
Bristol Myers reports progress in multiple myeloma trial with arlocabtagene autoleucel showing promise.
By Samoyed · Sep 9, 2026
Bristol Myers reports progress in multiple myeloma trial with arlocabtagene autoleucel showing promise.
Guidelines for e-signature use in global trials, including qualified e-signature and standard e-signature options.
Discover the KMCAR T-cell dose in the KOALA Phase I trial, a promising CAR‑T option for relapsed or refractory kappa‑restricted multiple myeloma patients.
When it comes to purchasing diamond rings, many people think of engagements as the only occasion to do so. However, lab grown diamond rings can...
© 2026 Vimeo Health. All rights reserved.
Theme by Auto UI Theme Builder.